| Patents for C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof (26,637) |
|---|
| 01/26/2012 | US20120021491 Identification of antigen or ligand-specific binding proteins |
| 01/26/2012 | US20120021403 Human Endogenous Retrovirus with Foamy-Like Properties and Uses Thereof |
| 01/26/2012 | US20120021001 Marked bovine viral diarrhea virus vaccines |
| 01/26/2012 | US20120020997 Multi plasmid system for the production of influenza virus |
| 01/26/2012 | US20120020995 Parapoxvirus vectors |
| 01/26/2012 | US20120020994 Multivalent, drying resistant, evolution-based vaccines |
| 01/26/2012 | US20120018313 Novel biotracers and uses thereof for controlling filtration plants |
| 01/26/2012 | CA2802430A1 Method for harvesting expression products |
| 01/26/2012 | CA2768866A1 High yield yellow fever virus strain with increased propagation in cells |
| 01/25/2012 | EP2408477A1 Replication-defective flavivirus vaccine vectors against respiratory syncytial virus |
| 01/25/2012 | EP1532167B1 Molecular antigen arrays using a virus like particle derived from the ap205 coat protein |
| 01/25/2012 | EP0791055B1 Method for producing biologicals in protein-free culture |
| 01/25/2012 | CN102333877A Methods and compositions for use of a coccidiosis vaccine |
| 01/25/2012 | CN102329809A Reverse genetic operating system of canine distemper virus (CDV)/R-20/8 vaccine strain and application thereof |
| 01/25/2012 | CN102329784A Japanese encephalitis virus like particles as well as preparation method and application thereof |
| 01/25/2012 | CN102329783A Prodenia litura gene engineering virus No.3 and building method thereof |
| 01/25/2012 | CN102329782A Avian flavivirus isolation strain and application thereof in preparation of vaccine |
| 01/25/2012 | CN102329780A Anti-mycoplasma ST (swine testis) cell, and methods for culturing hog cholera virus low virulent strain and preparing hog cholera attenuated vaccine using same |
| 01/25/2012 | CN102329777A Antiapoptosis high expression hVEGF165 (human Vascular Endothelial Growth Factor 165) cell model and building method thereof |
| 01/25/2012 | CN102327610A Method by utilizing rabbit-origin cells to produce swine fever live vaccine |
| 01/25/2012 | CN102327609A Production method of encephalitis B vaccine |
| 01/25/2012 | CN101372683B Artificial pseudovirus of human hepatitis C, and preparation and application thereof |
| 01/24/2012 | US8101172 Solenopsis invicta virus |
| 01/24/2012 | CA2461647C Lysin-deficient bacteriophages having reduced immunogenicity |
| 01/24/2012 | CA2410828C Duplexed parvovirus vectors |
| 01/24/2012 | CA2386920C Oncolytic virus |
| 01/24/2012 | CA2378802C Inactivated vaccine against feline calicivirus disease |
| 01/24/2012 | CA2295691C Methods and compositions for impairing multiplication of hiv-1 |
| 01/19/2012 | WO2012007589A1 Live attenuated parvovirus |
| 01/19/2012 | WO2012007557A1 Methods and reagents for obtaining transcriptionally active virus-like particles and recombinant virions |
| 01/19/2012 | WO2012007380A1 Modified viral strains, and method for improving the production of vaccine seeds of the influenza virus |
| 01/19/2012 | US20120015820 Methods and compositions for polypeptide engineering |
| 01/19/2012 | US20120015425 Cellular Permissivity Factor for Viruses and Uses Thereof |
| 01/19/2012 | US20120015424 Arginine Inactivation of Viruses |
| 01/19/2012 | US20120015423 Intergenic regions as novel sites for insertion of hiv dna sequences in the genome of modified vaccinia virus ankara |
| 01/19/2012 | US20120015344 Methods, compositions, and apparatus for the detection of viral strains |
| 01/19/2012 | US20120014992 N-Linked Glycosylation Alteration in E1 Glycoprotein of Classical Swine Fever Virus And Novel Classical Swine Fever Virus Vaccine |
| 01/19/2012 | US20120014988 Replication deficient recombinant viruses expressing antigens regulated by transcriptional control elements comprising multiple elements |
| 01/19/2012 | US20120014981 Avirulent, immunogenic flavivirus chimeras |
| 01/19/2012 | US20120014913 Process for preparing antiviral compounds |
| 01/19/2012 | CA2805643A1 Targeted nanoparticles for cancer and other disorders |
| 01/19/2012 | CA2804121A1 Modified viral strains, and method for improving the production of vaccine seeds of the influenza virus |
| 01/19/2012 | CA2802283A1 Live attenuated parvovirus |
| 01/18/2012 | EP2407534A1 Methods and reagents for obtaining transcriptionally active virus-like particles and recombinant virions |
| 01/18/2012 | EP2407480A1 Materials and methods for respiratory disease control in canines |
| 01/18/2012 | EP2407177A1 Adenovirus vaccine vectors |
| 01/18/2012 | EP2405945A2 Non-integrating retroviral vector vaccines |
| 01/18/2012 | EP1668120B1 Method for detecting cancer cells and monitoring cancer therapy |
| 01/18/2012 | CN102321669A Novel shRNA (short hairpin ribonucleic acid) for promoting animal growth and application thereof |
| 01/18/2012 | CN102321661A Eukaryotic expression recombinant plasmid and construction method thereof and Vero cell line stably expressing the plasmid |
| 01/18/2012 | CN102321639A Preparation method of virus-like particles (VLPs) of Chikungunya virus (CHIKV) and its application |
| 01/18/2012 | CN102321635A Preparation method for human papillomaviral empty capsid particles, and products thereof |
| 01/18/2012 | CN102321634A Preparation method of mink enteritis parvovirus empty capsid antigen particles |
| 01/18/2012 | CN102321591A Assembly mechanism of virus-like particle of hepatitis E virus and preparation method thereof |
| 01/18/2012 | CN102321590A Preparation method of asymmetric virus nanoparticles |
| 01/18/2012 | CN102321587A Construction of lung cancer drug screening cell line |
| 01/17/2012 | CA2501220C Vaccines against west nile virus |
| 01/17/2012 | CA2402117C Chimeric animal model susceptible to human hepatitis c virus infection |
| 01/12/2012 | WO2012006293A1 Norovirus derived immunogenic compositions and methods |
| 01/12/2012 | WO2012006145A2 Com positions and methods for retargeting virus constructs |
| 01/12/2012 | WO2012004323A1 Process for removing adventitious agents during the production of a virus in cell culture |
| 01/12/2012 | US20120010100 Plant farnesyltransferases |
| 01/12/2012 | US20120010092 Methods for Identifying Fragile Histidine Triad (FHIT) Interaction and Uses Thereof |
| 01/12/2012 | US20120009654 Monoparamunity inducers based on attenuated rabbit myxomaviruses |
| 01/12/2012 | US20120009624 Protein particles |
| 01/12/2012 | US20120009602 Reagents and Methods for Assessment of Human Tumor Malignancy and for Targeting Malignant Tumor Cells |
| 01/12/2012 | US20120009587 Recombinant adenovirus target-oriented co-expressing human p53 and p53aip1 |
| 01/12/2012 | US20120009569 Microorganism concentration process and device |
| 01/12/2012 | US20120009215 Influenza hemagglutinin and neuraminidase variants |
| 01/12/2012 | CA2804570A1 Process for removing adventitious agents during the production of a virus in cell culture |
| 01/12/2012 | CA2804501A1 Norovirus derived immunogenic compositions and methods |
| 01/11/2012 | EP2404933A2 HBV variants detection and application |
| 01/11/2012 | EP2403867A2 Assembly activating protein (aap) and its use for the manufacture of parvovirus particles essential consisting of vp3 |
| 01/11/2012 | EP2054515B1 Use of a phage displaying a peptide from an adhesion protein for treating a disease associated with intracellular formation of protein fibrillar inclusions or aggregates |
| 01/11/2012 | EP1546343B1 High titer recombinant aav production |
| 01/11/2012 | EP1248648B1 Vaccination against canine herpesvirus infection and vaccines |
| 01/11/2012 | CN102317449A Recombinant classical swine fever virus (CSFV) comprising a modified E2 protein and methods for generating said recombinant CSFV |
| 01/11/2012 | CN102311503A Recombinant human serum albumin / FGF fusion protein with continuous effect on restoration of a plurality of skin cells |
| 01/11/2012 | CN101935671B Method for constructing adenovirus core protein genetic marker vector |
| 01/11/2012 | CN101914502B I-type canine adenovirus attenuated vaccine strain and application thereof |
| 01/11/2012 | CN101875921B Method for separating and purifying hepatitis B virus particles |
| 01/11/2012 | CN101845439B Method for using silkworm cultured cell to express antibacterial peptide Cecropin B |
| 01/11/2012 | CN101591657B Thymosin beta4 gene expression inhibiting RNA and use thereof |
| 01/11/2012 | CN101407788B Method for promoting multiplication of rabies virus |
| 01/11/2012 | CN101052714B Stable and filterable enveloped virus formulations |
| 01/10/2012 | US8093209 Methods of suppressing microglial activation and systemic inflammatory responses |
| 01/10/2012 | US8093054 Metabolically activated recombinant viral vectors and methods for their preparation and use |
| 01/10/2012 | US8093042 Lentiviral triplex DNA, and vectors and recombinant cells containing lentiviral triplex DNA |
| 01/10/2012 | US8093033 Multi plasmid system for the production of influenza virus |
| 01/10/2012 | US8092791 Method of producing herpes simplex virus amplicons, resulting amplicons, and their use |
| 01/10/2012 | CA2455189C Methods for producing an active constituent of a pharmaceutical or a diagnostic agent in an mdck cell suspension culture |
| 01/10/2012 | CA2428073C Paramyxovirus vector for gene transfer to the cardiovascular system |
| 01/10/2012 | CA2214102C Group o hiv-1, fragments of such viruses, and uses thereof |
| 01/05/2012 | WO2012001075A2 Immortalized avian cell lines |
| 01/05/2012 | WO2011112089A3 Mutated rep encoding sequences for use in aav production |
| 01/05/2012 | US20120004125 Plant diacylglycerol acyltransferases |
| 01/05/2012 | US20120003742 Recombinant virus, escherichia coli retaining the same and a process for production thereof |
| 01/05/2012 | US20120003741 Hepatitis c virus expressing reporter tagged ns5a protein |
| 01/05/2012 | US20120003720 Nucleic acid derived from hepatitis c virus and expression vector, transformed cell, and hepatitis c virus particles each prepared by using the same |
| 01/05/2012 | US20120003719 INFECTIOUS GENOTYPE 1a, 1b, 2a, 2b, 3a, 5a, 6a and 7a HEPATITIS C VIRUS LACKING THE HYPERVARIABLE REGION 1 (HVR1) |